INTARCIA Trademark

Trademark Overview

On Tuesday, January 31, 2017, a trademark application was filed for INTARCIA with the United States Patent and Trademark Office. The USPTO has given the INTARCIA trademark a serial number of 87319506. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by Intarcia Therapeutics, Inc.. The INTARCIA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, pharmaceutical and medical research and development services; Research design and testing services for the research development of products in the fields of pharmaceuticals, biopharmaceuticals, science, medicine and drug delivery systems; research and development of new clinical products, drugs, pharmaceuticals and drug delivery systems and devices; and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals
intarcia

General Information

Serial Number87319506
Word MarkINTARCIA
Filing DateTuesday, January 31, 2017
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6175490
Registration DateTuesday, October 13, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements

Goods and ServicesScientific, pharmaceutical and medical research and development services; Research design and testing services for the research development of products in the fields of pharmaceuticals, biopharmaceuticals, science, medicine and drug delivery systems; research and development of new clinical products, drugs, pharmaceuticals and drug delivery systems and devices; and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 3, 2017
Primary Code042
First Use Anywhere DateSunday, October 31, 2004
First Use In Commerce DateSunday, October 31, 2004

Trademark Owner History

Party NameIntarcia Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameIntarcia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameIntarcia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Saturday, September 5, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 4, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 13, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 12, 2020USE AMENDMENT FILED
Wednesday, August 12, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, February 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 6, 2020EXTENSION 4 GRANTED
Thursday, February 6, 2020EXTENSION 4 FILED
Thursday, February 6, 2020TEAS EXTENSION RECEIVED
Tuesday, August 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, August 11, 2019EXTENSION 3 GRANTED
Sunday, August 11, 2019EXTENSION 3 FILED
Sunday, August 11, 2019TEAS EXTENSION RECEIVED
Wednesday, February 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 11, 2019EXTENSION 2 GRANTED
Monday, February 11, 2019EXTENSION 2 FILED
Monday, February 11, 2019TEAS EXTENSION RECEIVED
Wednesday, September 5, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 5, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 26, 2018EXTENSION 1 GRANTED
Thursday, July 19, 2018EXTENSION 1 FILED
Thursday, July 26, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 19, 2018TEAS EXTENSION RECEIVED
Tuesday, February 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 15, 2017ASSIGNED TO LIE
Tuesday, November 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 7, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, November 7, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 7, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, November 7, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, October 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 27, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 27, 2017NON-FINAL ACTION E-MAILED
Thursday, April 27, 2017NON-FINAL ACTION WRITTEN
Wednesday, April 26, 2017ASSIGNED TO EXAMINER
Friday, February 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

intarcia research pharmaceuticals delivery products drug development technologies fields systems obesity